(Q35135386)

6 August 2017

1 reference

title

Linezolid: in infants and children with severe Gram-positive infections (English)

1 reference

Katherine A Lyseng-Williamson

6 August 2017

main subject

gram-positive bacteria

0 references

1 reference

series ordinal

1

object named as

Katherine A Lyseng-Williamson

1 reference

6 August 2017

Karen L Goa

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

419-29; discussion 430-1

1 reference

Multidrug-resistant organisms in general pediatrics

6 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200305060-00009

21 January 2018

Oxazolidinones: a review

1 reference

12 December 2020

In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods

1 reference

12 December 2020

Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors

1 reference

12 December 2020

The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin

1 reference

12 December 2020

Single dose pharmacokinetics of linezolid in infants and children.

1 reference

12 December 2020

Pharmacogenetics in pediatrics. Implications for practice

1 reference

12 December 2020

Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.

1 reference

12 December 2020

Comparative activity of linezolid against staphylococci and enterococci isolated in Italy

1 reference

12 December 2020

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

1 reference

12 December 2020

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

1 reference

12 December 2020

In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus

1 reference

12 December 2020

1 reference

12 December 2020

Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release

1 reference

12 December 2020

Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.

1 reference

12 December 2020

Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management

1 reference

12 December 2020

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States

1 reference

12 December 2020

In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci

1 reference

12 December 2020

1 reference

12 December 2020

Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group

1 reference

12 December 2020

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

1 reference

12 December 2020

Linezolid for the treatment of resistant gram-positive cocci

1 reference

12 December 2020

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

1 reference

12 December 2020

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.

1 reference

12 December 2020

Dietary tyramine and other pressor amines in MAOI regimens: a review.

1 reference

12 December 2020

Serotonin syndrome and linezolid

1 reference

12 December 2020

Hematologic effects of linezolid: summary of clinical experience

1 reference

12 December 2020

Linezolid: MAOI activity and potential drug interactions

1 reference

12 December 2020

Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.

1 reference

12 December 2020

In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance.

1 reference

12 December 2020

A multicenter evaluation of linezolid antimicrobial activity in North America

1 reference

12 December 2020

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

1 reference

12 December 2020

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

1 reference

12 December 2020

In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method

1 reference

12 December 2020

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

1 reference

12 December 2020

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

1 reference

12 December 2020

Linezolid: an oxazolidinone antimicrobial agent

1 reference

12 December 2020

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands

1 reference

12 December 2020

Linezolid-induced pancytopenia

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Linezolid-Induced anemia and thrombocytopenia

1 reference

12 December 2020

Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci

1 reference

12 December 2020

Thrombocytopenia associated with linezolid therapy

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

1 reference

12 December 2020

Thrombocytopenia secondary to linezolid administration: what is the risk?

1 reference

12 December 2020

Linezolid resistance in a clinical isolate of Staphylococcus aureus

1 reference

12 December 2020

Linezolid: a review of its use in the management of serious gram-positive infections

1 reference

12 December 2020

Linezolid absolute bioavailability and the effect of food on oral bioavailability

1 reference

12 December 2020

Linezolid and serotonin syndrome

1 reference

12 December 2020

In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.

1 reference

12 December 2020

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam

1 reference

12 December 2020

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

1 reference

12 December 2020

In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials

1 reference

12 December 2020

10.2165/00128072-200305060-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1031788870

0 references

1 reference